We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI Model Identifies Signs of Disease Faster and More Accurately Than Humans

By LabMedica International staff writers
Posted on 25 Nov 2024

Traditionally, researchers and medical professionals identify pathology, or signs of disease, by meticulously examining and annotating tissue samples under a microscope, a process that can take hours for each slide or image. More...

Now, a "deep learning" artificial intelligence (AI) model can identify pathology in animal and human tissue images much more rapidly, and in many cases, with greater accuracy than humans. This development, outlined in Scientific Reports, could significantly accelerate disease-related research and holds promise for enhancing medical diagnoses, such as identifying cancer from biopsy images in just minutes.

To create the AI model, computer scientists at Washington State University (Pullman, WA, USA) trained it using images from prior epigenetic studies conducted by their team. These studies focused on molecular-level disease markers in tissues from rats and mice, including kidney, testes, ovarian, and prostate tissues. The researchers then tested the AI on images from additional studies, including those identifying breast cancer and lymph node metastasis. They discovered that the new AI model not only identified pathologies quickly but also did so faster than previous models, and in some cases, it detected instances that a trained human team had missed.

In epigenetic research, which examines changes to molecular processes influencing gene activity without altering the DNA itself, analysis can take years for large-scale studies. However, with the new AI model, the same data can be processed in just a few weeks. Deep learning is an advanced AI approach designed to replicate the human brain, surpassing traditional machine learning methods. This model is structured with a network of neurons and synapses. When the model makes an error, it "learns" from it using backpropagation, a technique that adjusts the network to correct the mistake, preventing it from happening again.

The research team developed the WSU deep learning model to process high-resolution, gigapixel images containing billions of pixels. To handle the large file sizes, which can slow down even powerful computers, the model analyzes smaller tiles of the image while maintaining their context within larger sections at lower resolution, similar to zooming in and out with a microscope. This model has already caught the attention of other researchers, with its potential to advance both research and diagnosis, especially in areas such as cancer and gene-related diseases. By using annotated images, such as those identifying cancer in tissue samples, researchers could train the AI model to perform similar tasks in medical settings.

“This AI-based deep learning program was very, very accurate at looking at these tissues,” said Michael Skinner, a WSU biologist and co-corresponding author on the paper. “It could revolutionize this type of medicine for both animals and humans, essentially better facilitating these kinds of analysis.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Urine Analyzer
respons® UDS100
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.